通用运动检测和预测的方法和算法:范围审查
Ahmed Taha Wesal1, Farida Hesham1, Mohamed A M Gad1
1Department of Systems and Biomedical Engineering, Cairo University, Giza, Egypt.
Expert review of medical devices
|February 16, 2026
概括
非EEG可穿戴传感器结合了皮电活动和运动数据,为检测通用性强力-克隆性发作 (GTCS) 提供了高准确度. 心率数据显示了发作预测的潜力,改善了的监测.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 数字健康数字健康
背景情况:
- 综合性强力-克隆性 (GTCS) 是一种严重的事件,与的突然意外死亡 (SUDEP) 有关.
- 持续监测发作对于控制耐药性至关重要.
- 非EEG可穿戴系统为传统的脑电图 (EEG) 提供了一个用户友好的替代方案,以提高舒适性和移动性.
研究的目的:
- 为了比较非EEG发作检测和预测的传感方式和计算方法.
- 为可穿戴监测系统确定有效的传感器组合.
- 突出目前可穿戴式发作检测和预测技术的研究缺口.
主要方法:
- 根据PRISMA-ScR指南进行了范围审查.
- 在Scopus,IEEE Xplore和PubMed数据库中搜索到2025年4月22日.
- 包括29项研究 (26项关于检测,3项关于预测).
主要成果:
- 将皮电活动 (EDA) 与运动传感器 (加速计,陀螺仪,sEMG) 结合起来,实现了95.2%的灵敏度和98.6%的精度来检测发作.
- 最好的检测模型的错误报警率 (FAR) 为每24小时0.64.
- 心率 (HR) 数据显示了预测的潜力,灵敏度为62%.
结论:
- 多模式非EEG可穿戴系统显示出个性化治疗的前景.
- 挑战包括系统验证,硬件限制和数据隐私问题.
- 未来的进步需要高效的AI,物联网集成,以患者为中心的设计和明确的监管框架.
相关概念视频
Seizures: Classification
1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Epilepsy and Seizures: Overview
1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
944
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
944


